34.50
전일 마감가:
$34.77
열려 있는:
$34.21
하루 거래량:
329.85K
Relative Volume:
0.37
시가총액:
$1.75B
수익:
$534.53M
순이익/손실:
$-11.45M
주가수익비율:
-143.10
EPS:
-0.2411
순현금흐름:
$48.28M
1주 성능:
+0.68%
1개월 성능:
+19.97%
6개월 성능:
-12.01%
1년 성능:
+18.17%
Atricure Inc Stock (ATRC) Company Profile
명칭
Atricure Inc
전화
513-755-4100
주소
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
ATRC
Atricure Inc
|
34.49 | 1.76B | 534.53M | -11.45M | 48.28M | -0.2411 |
|
ISRG
Intuitive Surgical Inc
|
357.32 | 125.08B | 11.03B | 3.16B | 2.83B | 8.7254 |
|
BDX
Becton Dickinson Co
|
153.95 | 42.57B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
MDLN
Medline Inc
|
39.62 | 32.88B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
67.94 | 34.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
196.22 | 28.81B | 5.54B | 1.52B | 1.74B | 10.37 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-18 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2026-02-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-12-17 | 재개 | JP Morgan | Overweight |
| 2024-04-23 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-29 | 개시 | UBS | Buy |
| 2021-08-05 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-12-18 | 재확인 | Needham | Buy |
| 2020-11-06 | 재확인 | Needham | Buy |
| 2020-04-07 | 개시 | Oppenheimer | Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2020-01-24 | 재확인 | Needham | Buy |
| 2019-08-13 | 다운그레이드 | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | 개시 | JP Morgan | Overweight |
| 2018-10-04 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Stifel | Buy |
| 2018-06-18 | 재확인 | Needham | Buy |
| 2018-04-27 | 재확인 | Needham | Buy |
| 2018-01-16 | 재확인 | Needham | Buy |
| 2017-11-02 | 재확인 | Needham | Buy |
| 2017-07-28 | 재확인 | Needham | Buy |
| 2017-05-30 | 재개 | Piper Jaffray | Overweight |
| 2016-06-30 | 재개 | JMP Securities | Mkt Outperform |
| 2015-10-28 | 재확인 | Needham | Buy |
| 2015-10-06 | 재확인 | Canaccord Genuity | Buy |
| 2015-10-06 | 재확인 | Needham | Buy |
모두보기
Atricure Inc 주식(ATRC)의 최신 뉴스
Citizens reiterates AtriCure stock rating on product growth outlook - Investing.com
AtriCure (ATRC) Proxy filing Summary - Quartr
(ATRC) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Needham Initiates AtriCure(ATRC.US) With Buy Rating, Announces Target Price $45 - Moomoo
Needham Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $45 - Moomoo
AtriCure (ATRC) Investor Day 2025 Summary - Quartr
Is AtriCure's (ATRC) Russell 2000 Defensive Debut Quietly Reframing Its Risk‑Reward Profile? - simplywall.st
AtriCure (ATRC) Jumps Nearly 7% as Healthcare Sector Sees Renewed InterestTotal Put Call - dars.gov.et
AtriCure to announce second quarter 2026 financial results - scanx.trade
AtriCure to Announce Second Quarter 2026 Financial Results - BioSpace
Form 4 AtriCure Inc For: 2 July By Investing.com - Investing.com Canada
AtriCure (ATRC) CEO adds 636 shares through 2018 Employee Stock Purchase Plan - Stock Titan
AtriCure, Inc. (ATRC) CSO acquires 636 ESPP shares at discount - Stock Titan
AtriCure (ATRC) CLO acquires 636 shares in ESPP purchase - Stock Titan
AtriCure (ATRC) COO adds ESPP shares in routine acquisition - Stock Titan
AtriCure (ATRC) CTO adds shares through discounted Employee Stock Purchase Plan - Stock Titan
AtriCure | 4: Statement of changes in beneficial ownership of securities-Officer Privitera Salvatore - Moomoo
Press Release: AtriCure to Announce Second Quarter 2026 Financial Results - Moomoo
GRANDEUR PEAK GLOBAL MICROCAP FUND's AtriCure Inc(ATRC) Holding History - GuruFocus
Enterprise value to revenue forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Price to book forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Price to sales forward of AtriCure, Inc. – NASDAQ:ATRC - TradingView
Canaccord reiterates AtriCure stock Buy rating after FDA clearance - Investing.com UK
Canaccord reiterates AtriCure stock Buy rating after FDA clearance By Investing.com - Investing.com Nigeria
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $55 - Moomoo
AtriCure (ATRC) Q2 2025 earnings summary - Quartr
AtriCure (ATRC) Joins Multiple Russell 2000 Defensive Indexes Is Its Risk Profile Evolving? - simplywall.st
Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic - MedTech Dive
AtriCure, Inc.(NasdaqGM: ATRC) added to Russell 2000 Defensive Index - marketscreener.com
AtriCure, Inc. Actuals & Estimates (NASDAQ:ATRC) - TradingView
AtriCure, Inc. Actuals & Estimates (DUS:A5I) - TradingView
ATRC Forecast — Price Target — Prediction for 2027 - TradingView
How (ATRC) Movements Inform Risk Allocation Models - Stock Traders Daily
AtriCure stock trades up with limited momentum as technical resistance remains - Traders Union
AtriCure Inc (ATRC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ATRC PE Ratio & Valuation, Is ATRC Overvalued - Intellectia AI
AtriCure stock jumps 6.19% as streamlined ablation integration takes spotlight, AtriCure reports - Traders Union
AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock? - Yahoo Finance
AtriCure Inc (ATRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AtriCure Inc (ATRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AtriCure Inc (ATRC) Institutional Confidence - TradingKey
AtriCure Inc (ATRC) Valuation: PE, PB & Fair Value Analysis - TradingKey
AtriCure Inc (ATRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AtriCure Inc (ATRC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
AtriCure Inc (ATRC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AtriCure Inc (ATRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AtriCure (ATRC) Holds Steady at $27.98: Consolidation Near Key Resistance LevelsHead and Shoulders - DonanımHaber
AtriCure (ATRC) Declines 2.8% as Shares Approach Critical Support at $26.58Sweep Order Flow - DonanımHaber
Trading Systems Reacting to (ATRC) Volatility - Stock Traders Daily
Do options traders know something about AtriCure stock we don't? - MSN
AtriCure (ATRC) Q1 2026 Earnings Transcript - AOL.com
Atricure Inc (ATRC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):